Molecular Cell: Bacteria Hide an Unusual Defense Mechanism That Activates When a Virus Attacks
21:24 14 October, 2026Researchers at the Gladstone Institutes have discovered an unusual bacterial defense mechanism that works in the opposite way to other known systems of this kind. The discovery could help researchers develop new tools for DNA editing, gene activity regulation, and antimicrobial drug development. The findings were published in the journal Molecular Cell.
Bacteria defend themselves against bacteriophages — viruses that infect bacterial cells. Some defense systems, known as retrons, detect a viral attack and trigger the production of a toxin that destroys the infected cell. This prevents the virus from multiplying and spreading to neighboring bacteria.
Previously, retrons were thought to operate according to a common principle: a toxin is present in the cell, but its activity is suppressed by short single-stranded DNA molecules. When a virus enters the cell, this inhibition is lifted, allowing the toxin to destroy the cell.
However, the type VI retrons studied by the research team work differently. In uninfected cells, they produce almost no single-stranded DNA or toxin. The production of protective DNA begins only after a bacteriophage enters the cell. Once enough DNA has accumulated, it interacts with an RNA molecule that blocks toxin production. This inhibition is lifted, and the cell begins producing a toxin that destroys its membrane.
Thus, unlike other retrons studied to date, these retrons use DNA not to suppress the activity of an existing toxin, but to trigger its production.
To uncover this mechanism, the researchers had to modify conventional experimental methods. In particular, they used Spacer-seq, a tool developed in their laboratory to monitor gene activity inside cells. This enabled them to detect extremely low levels of DNA production in uninfected bacteria and track how production increased following a viral attack.
The discovery could have practical applications. The team is investigating how the molecular mechanism of type VI retrons could be used to create synthetic sensors and switches that regulate gene activity. In the future, such systems could help researchers study diseases and develop treatments. The scientists are also exploring the possibility of using retron-produced toxins to develop new agents against bacteria that cause human disease.
The authors emphasize that the mechanism is currently a starting point for further research. Its potential medical applications have yet to be tested.